TickerGuard
Buy Day today: Neutral (47) Mixed market breadth · no major macro event
GYRE

Gyre Therapeutics Inc.

Healthcare · Biotechnology

7.00$ -0.6% vs. previous close Closing price · As of: Oct 7, 2026

Statements

Balance Sheet

Gyre Therapeutics Inc. (GYRE) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 199 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios
Annual Quarterly
Amounts Change % Common size %
Last 12 Full history
Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet GYRE
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
52 38 29 40 34 40 146 140 133 125 112 101 92 99 111 124 112 95 119 102 79 56 40 83 85 85 19 111 10.0 117 122 121 125 125 130 153 159 166 162 199
51 38 29 39 34 39 145 139 133 124 109 98 89 96 108 121 108 90 117 97 74 51 37 81 50 50 14 42 5.1 57 63 54 55 65 68 91 99 102 92 122
9.3 10 15 32 11 14 127 47 36 31 25 17 23 15 70 59 25 30 83 74 59 44 35 75 25 25 8.1 22 2.2 34 30 16 16 12 15 36 40 37 38 43
20 17 15 32 27 32 144 136 129 120 105 94 85 77 105 117 103 79 107 87 65 47 35 75 25 25 8.1 22 2.2 34 37 25 25 27 30 54 60 52 50 75
0.1 0.0 0.2 0.1 0.1 0.0 – – – – – – – 15 1.4 2.0 1.6 3.3 1.0 2.0 1.1 1.8 0.6 5.0 16 16 5.0 13 1.2 17 17 20 21 29 23 25 27 37 27 28
– – – – – – – – – – – – – – – – – – – – 0.0 – – – 6.1 6.1 5.7 5.3 1.2 4.3 4.9 5.6 6.4 6.3 7.9 8.9 8.9 10 11 11
– – – – – – – – – – – – – – – – – – – – – – – – – – -1.9 – – – – – – – – – – – – –
– – – – – – – – – – – – – – – – – – – – – – – – 1.9 1.9 26 25 1.7 1.7 1.7 1.7 1.7 1.7 5.1 5.0 4.8 6.2 4.6 4.5
32 22 15 9.3 9.5 8.7 3.0 2.6 3.5 5.0 6.1 7.8 11 30 13 15 18 19 15 17 18 15 13 4.3 13 13 11 14 6.4 103 33 28 27 27 25 23 22 24 25 34
32 22 15 9.3 9.5 8.7 2.9 2.4 3.3 4.8 4.4 6.2 9.1 29 12 14 17 18 14 16 17 14 13 4.3 12 12 6.8 13 1.8 20 19 16 15 20 19 17 16 18 20 29
30 19 13 5.8 5.5 5.1 – – – – 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.7 0.7 1.8 1.8 2.0 1.9 1.4 0.5 0.5 0.5 0.5 – 0.2 0.1 0.7 0.7 0.7 0.8 0.6 0.6 0.6 0.8 1.4
0.5 0.8 0.9 0.5 1.5 0.7 1.4 0.1 0.4 1.2 0.3 0.4 2.1 4.3 1.3 1.5 4.2 5.9 3.0 1.8 3.9 6.4 4.7 1.0 0.1 0.1 0.0 0.1 0.2 0.4 0.3 0.3 0.3 0.1 0.1 0.1 0.6 0.1 0.3 1.2
20 16 14 30 25 31 143 137 130 120 106 93 81 68 98 109 94 76 104 85 61 41 27 79 43 43 7.4 98 3.5 -16 57 60 63 63 68 92 102 106 101 130
-144 -148 -152 -162 -168 -173 -178 -185 -193 -203 -218 -232 -245 -259 -263 -280 -296 -315 -337 -357 -382 -403 -417 -366 10 10 -411 55 -415 -86 -78 -74 -73 -73 -71 -70 -67 -68 -78 -138
0.8 0.8 0.9 3.9 4.3 4.6 9.0 12 12 12 12 12 12 12 15 18 22 22 28 31 31 31 47 63 61 64 70 70 77 77 103 104 103 102 102 89 103 103 91 101

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?